Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q4 2024 Earnings

13NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-5.67

-3.88

-2.08

-0.29

Details

Expected EPS

-0.775779

Actual EPS

-0.51

Surprise EPS

0.27

Surprise Percent

+34.26%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.51 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.